Tatva Chintan Pharma Chem Limited (TATVA.NS)
Tatva Chintan Pharma Chem Limited operates in the Chemicals - Specialty industry of the Basic Materials sector, headquartered in Vadodara, GU, IN. The stock last traded at $1717.30, up 0.45% on the session, giving a market capitalisation of $40.17B. Its beta of 0.42 implies it has historically moved less than the broad market.
Tatva Chintan Pharma Chem Limited, an Indian-based enterprise, specializes in the production and distribution of diverse specialty chemicals. Its extensive product range encompasses essential components like structure-directing agents crucial for zeolite synthesis, phase transfer catalysts, and electrolyte salts vital for supercapacitor batteries. Furthermore, the company supplies pharmaceutical active pharmaceutical ingredients (APIs), agrochemical formulations, and various other specialized chemical products, including intermediates, disinfectants, catalytic agents, and solvents. Beyond manufacturing, Tatva Chintan engages in the trading of specialty chemicals and offers quaternary compounds (quats) and bulk drug substances. The firm's clientele spans a broad spectrum of sectors, such as the automotive, petrochemical, pharmaceutical, agricultural chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrance industries. Its global reach extends to approximately 25 nations, where its products are exported. Established in 1996, Tatva Chintan Pharma Chem Limited maintains its corporate headquarters in Vadodara, India.
Tatva Chintan Pharma Chem Limited is most often compared with the following Basic Materials names: